Autoreactive T cells target peripheral nerves in Guillain-Barré syndrome.
Nature
; 626(7997): 160-168, 2024 Feb.
Article
en En
| MEDLINE
| ID: mdl-38233524
ABSTRACT
Guillain-Barré syndrome (GBS) is a rare heterogenous disorder of the peripheral nervous system, which is usually triggered by a preceding infection, and causes a potentially life-threatening progressive muscle weakness1. Although GBS is considered an autoimmune disease, the mechanisms that underlie its distinct clinical subtypes remain largely unknown. Here, by combining in vitro T cell screening, single-cell RNA sequencing and T cell receptor (TCR) sequencing, we identify autoreactive memory CD4+ cells, that show a cytotoxic T helper 1 (TH1)-like phenotype, and rare CD8+ T cells that target myelin antigens of the peripheral nerves in patients with the demyelinating disease variant. We characterized more than 1,000 autoreactive single T cell clones, which revealed a polyclonal TCR repertoire, short CDR3ß lengths, preferential HLA-DR restrictions and recognition of immunodominant epitopes. We found that autoreactive TCRß clonotypes were expanded in the blood of the same patient at distinct disease stages and, notably, that they were shared in the blood and the cerebrospinal fluid across different patients with GBS, but not in control individuals. Finally, we identified myelin-reactive T cells in the nerve biopsy from one patient, which indicates that these cells contribute directly to disease pathophysiology. Collectively, our data provide clear evidence of autoreactive T cell immunity in a subset of patients with GBS, and open new perspectives in the field of inflammatory peripheral neuropathies, with potential impact for biomedical applications.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Nervios Periféricos
/
Autoinmunidad
/
Enfermedades del Sistema Nervioso Periférico
/
Células TH1
/
Linfocitos T CD8-positivos
/
Síndrome de Guillain-Barré
Tipo de estudio:
Etiology_studies
Límite:
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article